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263.8mg/dL, 42% were females and 31.3% were diagnosed with
diabetes mellitus. The mean pre-switch LDL-C was 143mg/dL,
mean post-switch LDL-C was 126.6mg/dL, mean percentage
reduction was 7.8%, and the mean time before the ﬁnal switch
was 143.6 days (median 80 days). In a paired comparison test,
the reduction in post-switch LDL-C was signiﬁcant at < 1%. In
a multivariate analysis, the time to switch to higher potency after
LDL-C measurement has no signiﬁcant effect on post-switch
LDL-C reduction. After switch 42 (27.45%) attained goal LDL-
C level. CONCLUSIONS: Switching to higher potency statins
reduces LDL-C levels by only an additional eight percent (8%)
resulting in majority (72.55%) of the patients in clinical practice
failing to attain recommended LDL-C goal even after up titra-
tion on statins.
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OBJECTIVES: Assess TC goal (<5mmol/L) attainment among
CHD/CHD equivalent patients and nonCHD patients with mul-
titple risk factors that were prescribed lipid-lowering drugs
(LLD). METHODS: Retrospective cohort study at 44 randomly
selected centres across Hungary (30 primary care and 14 outpa-
tient lipid centres). Physicians at selected centers consecutively
identiﬁed 10 eligible patients. Adults (>=18 years) that were
either CHD/CHD equivalent or nonCHD with multiple risk
factors and prescribed lipid lowering therapy were eligible. Date
of ﬁrst LLD was considered as index date, medical records were
reviewed by physicians to collect patient characteristics, baseline
and follow-up laboratory values, treatment, and resources use
data. RESULTS: A total of 440 patients (71% CHD/CHD equiv-
alent patients and 29% nonCHD with multiple risk factors) were
included in the study. Mean age was 61.5 years (SD 10.3), 51.5%
were female; mean baseline TC for CHD/CHD equivalent
patients was 6.9mmol/L (SD 1.6) and 7.3mmol/L (SD 1.4) for
nonCHD patients. Statins were initial LLD in 75.9% patients
followed by ﬁbrates (23.6%). The majority (87%) were initiated
either on simvastatin 10mg or simvastatin 20mg, or equipotent
statin. Of the patient not at goal at baseline 31% CHD and 23%
nonCHD patients attained TC goal at the end of the study
period. In a logistic model for goal attainment, patients with high
baseline TC (OR = 0.53 95% CI 0.35–0.80) and having ﬁbrates
as initial LLD (OR = 0.39 95% CI 0.22–0.73) compared to those
with statins as initial LLD were less likely to reach goal. CON-
CLUSIONS: Overall, only 15% attained TC goal on initial LLD,
and only an additional 11% attained goal after change in LLD,
resulting in 74% of patients not attaining goal with current LLD
dominated by statins. More effective therapy is needed in these
patients to help achieve their cholesterol goals.
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OBJECTIVES: Propensity score matching (PSM) is a method
used to address selection bias in observational studies and to date
has been used mainly in survival analysis. This study has used
PSM when determining antenatal costs for alternative referral
modes (via telemedicine (TM) or direct referral) for obtaining
specialist advice for pregnant women at risk of a fetal cardiac
anomaly. METHODS: Three district hospitals (DH) in south-
east England were offered the use of a fetal cardiology telemedi-
cine service. Two hospitals (DH1 and DH3) continued to refer
all patients directly to London, while the third hospital (DH4)
used both referral modes. A logistic regression model was ﬁtted
to women in DH4 in order to predict what proportions of
women in DH1 and DH3 would have been seen via TM, had
that service been taken up. PSM was then used to match “TM”
cases to “direct referral” cases. A total cost per woman was
obtained for all antenatal resource use incurred during the study
and the costs were adjusted for those predicted as TM cases.
Finally, the costs for the predicted modes and matched modes
were compared. RESULTS: The logistic regression model pre-
dicted 153 women be assessed via TM and the remainder (n =
84) as direct referrals. Mean antenatal cost per patient for the
TM group was slightly higher (stg606), although not signiﬁ-
cantly so, compared with the direct referral group (stg561). After
applying PSM, 66 TM cases were matched to 55 direct cases.
The magnitudes of the PSM costs (TM group, stg671, and direct
group, stg551) were similar to the logistic regression model.
Comparisons of cost results by referral mode and analytical
method were not statistically signiﬁcant. CONCLUSIONS: PSM
indicated that the cost results from the logistic regression model
were reliable. We conclude that there is a role for PSM in eco-
nomic evaluation.
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OBJECTIVE: Administrative claims data are widely used to
study disease treatment patterns and costs. A valid, claims-based
deﬁnition method is needed to identify patients with chronic
angina (CA) from these data. METHODS: Five cardiologists and
one internist with claims-coding expertise developed an initial
series of increasingly speciﬁc, claims-based deﬁnitions of CA.
Claims data from 2001 to 2002 were used to determine the
number and demographic characteristics of patients who met
these criteria. This information was used to determine a ﬁnal 
deﬁnition for patients with CA that has acceptable levels of 
qualitatively assessed sensitivity and speciﬁcity. RESULTS: The
panel reviewed relative patient count and demographic infor-
mation and developed the following claims-based deﬁnition for
CA: Patients aged ° 35 years who were: a) diagnosed at least
twice with CA (ICD-9-CM codes 413.xx) and ﬁlled two nitrate,
beta-blocker or calcium channel blocker prescriptions with at
least 30 days between prescriptions; b) ﬁlled two nitrate pre-
scriptions, were diagnosed with chest pain (ICD-9-CM 786.50,
786.51 or 786.59), and were either diagnosed with coronary
artery disease (CAD) or had a CAD-related procedure; or c) ﬁlled
two nitrate prescriptions with at least 30 days between pre-
scriptions, were diagnosed with CAD and had one CA claim.
CONCLUSIONS: Patients with CA can be identiﬁed from
administrative claims data with different levels of speciﬁcity and
sensitivity. More studies are needed to conﬁrm criteria validity
of these criteria and to examine the clinical and economic impact
of CA in contemporary medical practice.
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